Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05322837

Tracking of Upper Limb Sensory and Motor Recovery in Asian Stroke Survivors

As Singapore's population is aging rapidly, the incidence rate of stroke has been increasing in the past years. Rehabilitation is essential for the resumption of daily activities, and with the appropriate care, it is possible for stroke-survivors to regain most of their functions.

Hence, this study aims to better understand upper limb recovery covering different stages post-stroke in a representative cohort of Asian adults

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Tan Tock Seng Hospital

Singapore

Location status: Recruiting

Location contact

Dr Karen Chua, MBBS

PRINCIPAL_INVESTIGATOR

Wei Binh Chong

CONTACT

[email protected]

63578225

About this study

Stroke is a leading contributor to disability in Singapore, partially driven by a reduced ability to use the upper limb in their daily lives. Reduced upper limb use commonly results from a variety of impairments such as motor, sensory and cognitive impairments.

The aim of this longitudinal and observational study is to gather a rich multi-modal database on the time-course of upper limb recovery in a representative cohort after stroke and characterise the relationship between upper limb recovery, common post-stroke impairments and quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stroke confirmed by neurologists, neurosurgeons and brain imaging (CT, CT angiogram, MRI, MR angiogram)
  • First ever confirmed stroke
  • Asian ethnicity
  • Age 21-90 years
  • Montreal Cognitive Assessment (MOCA) scores 21/30 and above
  • Admission to rehabilitation ward is within 8 weeks of stroke onset

Exclusion criteria

  • Recurrent stroke or transient ischaemic attack (TIA)
  • Upper limb impairment not related to stroke: e.g., subarachnoid haemorrhage, traumatic brain injury or brain tumours
  • Bilateral upper limb impairment.
  • Uncontrolled medical conditions such as hypertension, hypotension, diabetes mellitus, unstable angina, cardiac failure or sepsis will be excluded.
  • Active fractures or arthritis of upper limb joints/bones
  • Visual Analogue Scale (VAS) pain > 5/10
  • MOCA < 21/30
  • Severe behavioural disturbance or agitation or epilepsy or untreated depression
  • Life expectancy < 6 months
  • End organ failures on replacements (renal dialysis or renal replacement therapies)
  • Minimally responsive or unresponsive awareness (vegetative) states
  • Pregnancy or lactation states
  • Admission to rehab ward later than 8 weeks post-stroke
  • (For TMS assessments only) History of epilepsy or seizures, or cranial surgeries, or have metal implants in body or head, or have implanted electronics, or have metallic valve, or skull fracture or brain injury, or head or brain surgeries.

Treatment and study plan

Clinical and technological-aided assessments and questionnaires

Other

Assessments and questionnaires related to upper limb function and quality of life will be used

Primary outcomes

  1. Fugl-Meyer Assessment (FMA)

    Time frame: Inpatient: week 1 of admission

    The FMA-UE is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, in patients with post-stroke hemiplegia.

Study contacts

Contact information is provided by the study sponsor or research team.

Megan Lau Si En

CONTACT

[email protected]

68894580

Sponsors and collaborators

Lead sponsor

Tan Tock Seng Hospital

Other

Collaborators

  • Rehabilitation Research Institute of Singapore (RRIS)
  • Singapore-ETH Centre (SEC)

Registry information

Official study title

Deep Phenotyping of Upper Limb Sensori-motor Recovery in Asian Stroke Survivors: Concept, Development and Implementation of a Rehabilomics-driven Technology-assisted Data Platform

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Apr 12, 2022
Registry last updated
Apr 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.